Jagsonpal Pharmaceuticals Ltd.
FDA inspection history in Bhiwadi, India, 2024 to 2025
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2024: one Form 483; 2025: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2024–25One Form 483 and one warning letter, at Bhiwadi, India.
Cited most
Across all Jagsonpal Pharmaceuticals observations on file
- 21 CFR 211.160General requirements1
- 21 CFR 211.180General requirements1
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.194Laboratory records1
The complete Jagsonpal Pharmaceuticals file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Bhiwadi, India
One Form 483 · 2024 · 4 observations
Latest: Form 483, Apr 3, 2024 →
Also: one document not tied to a site.
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-02-05 | Warning letter Warning letter | — | — | $99 |
| 2024-04-03 | 483 Form 483 | Bhiwadi, India | 4 | $99 |
Investigators on these documents
FEI number 3004153045 · most recent document Feb 5, 2025
About Jagsonpal Pharmaceuticals Ltd.
How many FDA Form 483s has Jagsonpal Pharmaceuticals Ltd. received?
FDA Intel has 1 Form 483 on file for Jagsonpal Pharmaceuticals Ltd.; the most recent is dated Apr 3, 2024.
When was Jagsonpal Pharmaceuticals Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Jagsonpal Pharmaceuticals Ltd. is a Form 483 dated Apr 3, 2024, for the site in Bhiwadi, India.
What did FDA cite at Jagsonpal Pharmaceuticals Ltd.?
The regulations cited most in the observations on file for Jagsonpal Pharmaceuticals Ltd. are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.180 (General requirements), 1 time; 21 CFR 211.188 (Batch production and control records), 1 time.
Has Jagsonpal Pharmaceuticals Ltd. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Jagsonpal Pharmaceuticals Ltd.; the most recent is dated Feb 5, 2025.